Analyze Portfolio
NYSE · Healthcare

UNITEDHEALTH GROUP INC (UNH)

As-reported financials and recent SEC filings for UNITEDHEALTH GROUP INC, latest fiscal period FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About UNITEDHEALTH GROUP INC

UnitedHealth Group is a health care and well-being company operating through two main businesses: Optum and UnitedHealthcare. Optum provides information and technology-enabled health services including patient care, data analytics, and pharmacy care services to patients, care providers, payers, employers, governments, and life sciences companies. UnitedHealthcare offers health benefits to individuals, employers, seniors, and economically disadvantaged populations to simplify access to affordable, high-quality care.

Snapshot

Revenue
$447.57B
Revenue growth (YoY)
11.8%
Net income
$12.06B
Diluted EPS
$13.23
Gross margin
Operating margin
4.2%
Net margin
2.7%
FCF margin
3.6%
ROE
12.0%
P/E (TTM)
31.4×
Market cap
$379.28B
Debt / equity
0.7×

Fundamentals are from SEC filings. P/E and market cap are derived from recent market prices, refreshed on a rolling basis (typically within the past week).

What changed at Unitedhealth Group

  • Revenue grew 11.8% to $447.6B in FY2025, faster than the 7.7% the year before.
  • Operating margin is 4.2% in FY2025, -4.1 pp against 8.3% in FY2021.
  • Most recent quarter Q1 FY2026: revenue $111.7B, up 2.0% from Q1 FY2025.
  • Free cash flow was $16.1B in FY2025, 3.6% of revenue.
  • Net income fell 16.3% to $12.1B in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Unitedhealth Group’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Operating margin4.2%
57th percentile of 397
Net margin2.7%
58th percentile of 416
FCF margin3.6%
51st percentile of 371
Revenue growth (YoY)+11.8%
54th percentile of 538
ROE12.0%
77th percentile of 474
P/E (TTM)31.4×
64th percentile of 203
Debt / equity0.72×
65th percentile of 243
Short interest3.46d
30th percentile of 557

No open-market insider transactions recorded in the last 90 days. For context, about 16% of companies in the universe saw any open-market insider buying in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 10 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F (latest Q1 2026).

Conviction investors
10
+7 quant / multi-strat
Initiated / added
11
1 new, 10 added
Reduced / exited
12
6 trimmed, 6 exited
Combined position
$5.23B
reported long value
InvestorAs ofPosition valueSharesChange
Dodge & CoxQ1 2026$2.56B9.5MAdded
Two Sigma InvestmentsquantQ1 2026$460.1M1.7MAdded
Citadel AdvisorsquantQ1 2026$417.3M1.5MReduced
Millennium ManagementquantQ1 2026$367.1M1.4MAdded
D. E. ShawquantQ1 2026$315.8M1.2MAdded
Renaissance TechnologiesquantQ1 2026$313.5M1.2MAdded
AQR Capital ManagementquantQ1 2026$260.0M977.4KAdded
Ruane Cunniff (Sequoia)Q1 2026$197.1M728.4KReduced
Point72 Asset ManagementquantQ1 2026$113.5M419.5KReduced
Tiger Global ManagementQ1 2026$94.8M350.4KReduced
Yacktman Asset ManagementQ1 2026$45.6M168.5KAdded
AppaloosaQ1 2026$24.4M90.0KReduced
Gotham Asset ManagementQ1 2026$23.3M86.1KAdded
Soros Fund ManagementQ1 2026$17.6M65.0KAdded
First Eagle Investment ManagementQ1 2026$11.0M40.8KAdded
Markel GroupQ1 2026$5.1M18.7KReduced
Hound PartnersQ1 2026$1.2M4.6KNew

No longer held by: Berkshire Hathaway (as of Q1 2026), Bridgewater Associates (as of Q1 2026), Harris Associates (Oakmark) (as of Q1 2026), Polen Capital Management (as of Q1 2026), Viking Global Investors (as of Q1 2026), Scion Asset Management (as of Q3 2025)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
open-market
Bought (90d)
open-market value
Sells (90d)
0
Signal
Quiet
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-04-23
filed 2026-04-27
Conway Patrick HughChief Executive Officer, OptumSell800$355.00$284K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
17.3M
settled 2026-07-15
Change vs prior
-5.8%
vs previous settlement
Days to cover
3.46
at avg daily volume
Avg daily volume
5.0M
FINRA reported
SettlementShares shortChangeDays to cover
2026-07-1517.3M-5.8%3.46
2026-06-3018.4M+7.2%2.65
2026-06-1517.2M-10.9%2.31
2026-05-2919.3M+10.4%3.04
2026-05-1517.5M-10.5%2.58
2026-04-3019.5M+28.6%1.93
2026-04-1515.2M-14.2%1.88
2026-03-3117.7M-0.9%1.80

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$447.57B$400.28B$371.62B$324.16B$287.60B
Gross profit$256.56B
Operating income$18.96B$32.29B$32.36B$28.43B$23.97B
Net income$12.06B$14.40B$22.38B$20.12B$17.29B
Diluted EPS$13.23$15.51$23.86$21.18$18.08

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$19.70B$24.20B$29.07B$26.21B$22.34B
Capital expenditure$3.62B$3.50B$3.39B$2.80B$2.45B
Free cash flow$16.07B$20.70B$25.68B$23.40B$19.89B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q1 FY2026$111.72B2.0%$6.28B$6.90
Q4 FY2025$113.22B12.3%$10.0M$0.01
Q3 FY2025$113.16B12.2%$2.35B$2.59
Q2 FY2025$111.62B12.9%$3.41B$3.74
Q1 FY2025$109.58B9.8%$6.29B$6.85
Q4 FY2024$100.81B6.8%$5.54B$5.99
Q3 FY2024$100.82B9.2%$6.05B$6.51
Q2 FY2024$98.86B6.4%$4.22B$4.54

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorHealthcare
SIC industryHospital & Medical Service Plans
Fiscal year endDecember 31
Latest fiscal periodFY2025
SEC filings since2020
SEC CIK731766

Recent SEC filings

10-K2026-03-02
View on EDGAR →
10-K2025-02-27
View on EDGAR →
10-Q2026-05-05
View on EDGAR →
10-Q2025-10-28
View on EDGAR →
10-Q2025-08-11
View on EDGAR →
10-Q2025-05-07
View on EDGAR →
8-K2026-07-16
View on EDGAR →
8-K2026-06-05
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

UNH head to head

Monitor UNH

Get an alert when Unitedhealth Group files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor UNH free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.